A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Chang Gung Memorial Hospital
Chinese PLA General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Medical College of Wisconsin
Alexion Pharmaceuticals, Inc.
Khyber Medical University Peshawar
Boston Medical Center
The Affiliated Hospital of Qingdao University
Yale University
The First Affiliated Hospital of Xiamen University
Zhejiang Cancer Hospital
Serum Institute of India Pvt. Ltd.
Vall d'Hebron Institute of Oncology
Sun Yat-sen University
HonorHealth Research Institute
Ospedale Santa Croce-Carle Cuneo
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The Affiliated Hospital of Xuzhou Medical University
National Institute for Tuberculosis and Lung Diseases, Poland
Lithuanian University of Health Sciences
Ospedale Regina Montis Regalis
University of Leeds
Hospital de Clinicas de Porto Alegre
Barbara Ann Karmanos Cancer Institute
Medical University of Vienna